Michael Panzara
Director/Board Member chez ATHIRA PHARMA, INC.
Fortune : - $ au 31/03/2024
Profil
Michael Panzara is an Independent Director at Athira Pharma, Inc. and the Chief Medical Officer at Neurvati Neurosciences, Inc. He was previously a Director at Wave Life Sciences UK Ltd.
from 2016 to 2022, the Chief Medical Officer-Neurology & Vice President at Biogen, Inc. from 2001 to 2009, and the Head-Multiple Sclerosis & Neurology at Genzyme Corp.
from 2009 to 2016.
He also served as the Chief Medical Officer & Head-Therapeutics at Wave Life Sciences Ltd.
from 2020 to 2022.
Panzara received his undergraduate degree from the University of Pennsylvania, his graduate degree from Harvard T.H.
Chan School of Public Health, and another undergraduate degree from Stanford University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ATHIRA PHARMA, INC.
-.--% | 26/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Michael Panzara
| Sociétés | Poste | Début |
|---|---|---|
| ATHIRA PHARMA, INC. | Director/Board Member | 18/03/2022 |
| Neurvati Neurosciences, Inc. | Chief Tech/Sci/R&D Officer | 01/10/2022 |
Anciens postes connus de Michael Panzara
| Sociétés | Poste | Fin |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Chief Tech/Sci/R&D Officer | 14/10/2022 |
Wave Life Sciences UK Ltd.
 Wave Life Sciences UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Wave Life Sciences Ltd., Wave Life Sciences UK Ltd. is a pharmaceutical company founded in 2017. The private company is based in Birmingham, UK and specializes in manufacturing pharmaceutical products. | Director/Board Member | 01/01/2022 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/07/2016 |
| BIOGEN INC. | Corporate Officer/Principal | 01/09/2009 |
Formation de Michael Panzara
| University of Pennsylvania | Undergraduate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
| Stanford University School of Medicine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| ATHIRA PHARMA, INC. | Health Technology |
| WAVE LIFE SCIENCES LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Wave Life Sciences UK Ltd.
Wave Life Sciences UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Wave Life Sciences Ltd., Wave Life Sciences UK Ltd. is a pharmaceutical company founded in 2017. The private company is based in Birmingham, UK and specializes in manufacturing pharmaceutical products. | Health Technology |
| Neurvati Neurosciences, Inc. |
